company background image
ROSS

Rossari Biotech NSEI:ROSSARI Stock Report

Last Price

₹863.10

Market Cap

₹47.4b

7D

0.8%

1Y

-29.5%

Updated

22 Jun, 2022

Data

Company Financials +
ROSSARI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends0/6

ROSSARI Stock Overview

Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally.

Rossari Biotech Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Rossari Biotech
Historical stock prices
Current Share Price₹863.10
52 Week High₹1,619.00
52 Week Low₹795.10
Beta0
1 Month Change-2.89%
3 Month Change-8.12%
1 Year Change-29.47%
3 Year Changen/a
5 Year Changen/a
Change since IPO16.38%

Recent News & Updates

Shareholder Returns

ROSSARIIN ChemicalsIN Market
7D0.8%-2.0%-1.6%
1Y-29.5%-2.9%-1.6%

Return vs Industry: ROSSARI underperformed the Indian Chemicals industry which returned -2.9% over the past year.

Return vs Market: ROSSARI underperformed the Indian Market which returned -1.6% over the past year.

Price Volatility

Is ROSSARI's price volatile compared to industry and market?
ROSSARI volatility
ROSSARI Average Weekly Movement4.4%
Chemicals Industry Average Movement6.7%
Market Average Movement6.9%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.4%

Stable Share Price: ROSSARI is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: ROSSARI's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003651Sunil Charihttps://www.rossari.com

Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers home, personal care and performance chemical products, including soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names.

Rossari Biotech Fundamentals Summary

How do Rossari Biotech's earnings and revenue compare to its market cap?
ROSSARI fundamental statistics
Market Cap₹47.40b
Earnings (TTM)₹976.74m
Revenue (TTM)₹14.83b

48.5x

P/E Ratio

3.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ROSSARI income statement (TTM)
Revenue₹14.83b
Cost of Revenue₹11.05b
Gross Profit₹3.78b
Other Expenses₹2.80b
Earnings₹976.74m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)17.74
Gross Margin25.48%
Net Profit Margin6.59%
Debt/Equity Ratio1.0%

How did ROSSARI perform over the long term?

See historical performance and comparison

Dividends

0.06%

Current Dividend Yield

3%

Payout Ratio

Does ROSSARI pay a reliable dividends?

See ROSSARI dividend history and benchmarks
When do you need to buy ROSSARI by to receive an upcoming dividend?
Rossari Biotech dividend dates
Ex Dividend DateJul 07 2022
Dividend Pay DateAug 14 2022
Days until Ex dividend14 days
Days until Dividend pay date52 days

Does ROSSARI pay a reliable dividends?

See ROSSARI dividend history and benchmarks
We’ve recently updated our valuation analysis.

Valuation

Is ROSSARI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ROSSARI?

Other financial metrics that can be useful for relative valuation.

ROSSARI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.2x
Enterprise Value/EBITDA25.5x
PEG Ratio1.5x

Price to Earnings Ratio vs Peers

How does ROSSARI's PE Ratio compare to its peers?

ROSSARI PE Ratio vs Peers
The above table shows the PE ratio for ROSSARI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average42.8x

Price-To-Earnings vs Peers: ROSSARI is expensive based on its Price-To-Earnings Ratio (48.5x) compared to the peer average (42.8x).


Price to Earnings Ratio vs Industry

How does ROSSARI's PE Ratio compare vs other companies in the Indian Chemicals Industry?

Price-To-Earnings vs Industry: ROSSARI is expensive based on its Price-To-Earnings Ratio (48.5x) compared to the Indian Chemicals industry average (16.6x)


Price to Earnings Ratio vs Fair Ratio

What is ROSSARI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ROSSARI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio48.5x
Fair PE Ratio29.3x

Price-To-Earnings vs Fair Ratio: ROSSARI is expensive based on its Price-To-Earnings Ratio (48.5x) compared to the estimated Fair Price-To-Earnings Ratio (29.3x).


Share Price vs Fair Value

What is the Fair Price of ROSSARI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ROSSARI (₹863.1) is trading above our estimate of fair value (₹813.46)

Significantly Below Fair Value: ROSSARI is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: ROSSARI is poor value based on its PEG Ratio (1.5x)


Discover undervalued companies

Future Growth

How is Rossari Biotech forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


32.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ROSSARI's forecast earnings growth (32.4% per year) is above the savings rate (6.7%).

Earnings vs Market: ROSSARI's earnings (32.4% per year) are forecast to grow faster than the Indian market (17.3% per year).

High Growth Earnings: ROSSARI's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ROSSARI's revenue (19.1% per year) is forecast to grow faster than the Indian market (11.5% per year).

High Growth Revenue: ROSSARI's revenue (19.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ROSSARI's Return on Equity is forecast to be high in 3 years time (22.1%)


Discover growth companies

Past Performance

How has Rossari Biotech performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


25.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ROSSARI has high quality earnings.

Growing Profit Margin: ROSSARI's current net profit margins (6.6%) are lower than last year (11.3%).


Past Earnings Growth Analysis

Earnings Trend: ROSSARI's earnings have grown significantly by 25.9% per year over the past 5 years.

Accelerating Growth: ROSSARI's earnings growth over the past year (21.8%) is below its 5-year average (25.9% per year).

Earnings vs Industry: ROSSARI earnings growth over the past year (21.8%) underperformed the Chemicals industry 29.6%.


Return on Equity

High ROE: ROSSARI's Return on Equity (12.1%) is considered low.


Discover strong past performing companies

Financial Health

How is Rossari Biotech's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: ROSSARI's short term assets (₹6.1B) exceed its short term liabilities (₹2.9B).

Long Term Liabilities: ROSSARI's short term assets (₹6.1B) exceed its long term liabilities (₹1.6B).


Debt to Equity History and Analysis

Debt Level: ROSSARI has more cash than its total debt.

Reducing Debt: ROSSARI's debt to equity ratio has reduced from 41.2% to 1% over the past 5 years.

Debt Coverage: ROSSARI's debt is well covered by operating cash flow (348.4%).

Interest Coverage: ROSSARI's interest payments on its debt are well covered by EBIT (10.7x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Rossari Biotech current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.058%

Current Dividend Yield

Upcoming Dividend Payment

TodayJun 23 2022Ex Dividend DateJul 07 2022Dividend Pay DateAug 14 202238 days from Ex DividendBuy in the next 14 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: ROSSARI's dividend (0.058%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.44%).

High Dividend: ROSSARI's dividend (0.058%) is low compared to the top 25% of dividend payers in the Indian market (1.93%).


Stability and Growth of Payments

Stable Dividend: ROSSARI is not paying a notable dividend for the Indian market, therefore no need to check if payments are stable.

Growing Dividend: ROSSARI is not paying a notable dividend for the Indian market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: ROSSARI is not paying a notable dividend for the Indian market.


Cash Payout to Shareholders

Cash Flow Coverage: ROSSARI is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure


CEO

Sunil Chari (56 yo)

19.42yrs

Tenure

₹9,000,000

Compensation

Mr. Sunil Srinivasan Chari serves as a Managing Director of Rossari Biotech Limited since September 26, 2019 and serves as its Director since 2009. He is a co-founder of Rossari Biotech Limited in 2003. He...


CEO Compensation Analysis

Compensation vs Market: Sunil's total compensation ($USD115.24K) is below average for companies of similar size in the Indian market ($USD342.82K).

Compensation vs Earnings: Sunil's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: ROSSARI's management team is considered experienced (2.6 years average tenure).


Board Members

Experienced Board: ROSSARI's board of directors are considered experienced (3.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Rossari Biotech Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Rossari Biotech Limited
  • Ticker: ROSSARI
  • Exchange: NSEI
  • Founded: 2003
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Implied Market Cap: ₹47.395b
  • Shares outstanding: 55.06m
  • Website: https://www.rossari.com

Number of Employees


Location

  • Rossari Biotech Limited
  • 201 A & B, Akruti Corporate Park
  • 2nd Floor
  • Mumbai
  • Maharashtra
  • 400078
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/22 00:00
End of Day Share Price2022/06/22 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.